Lecture: PSA Screening - Where East meets West

Lecture: Current use of systemic therapies in localised disease

Lecture: Current standard of care in advanced disease

Lecture: Exploring the androgen signalling pathway in CRPC

Lecture: Clinical perspectives: Non-AR therapeutic targets in CRPC

Debate: Will chemotherapy continue to be standard treatment for symptomatic mCRPC in the era of novel agents? (for)

Debate: Will chemotherapy continue to be standard treatment for symptomatic mCRPC in the era of novel agents? (against)

Lecture: Clinical Perspectives: How far are we from personalising treatment for prostate cancer patients?

Vitamin D as a prevention against breast cancer

Idelalisib shows promising results in patients with double refractory indolent B-cell non-Hodgkin's lymphoma

Rituximab versus idelalisib in refractory CLL

New agents extend progression-free survival in double refractory myeloma